BioSpace News Archive

Lone Star Bio

Drug for Pancreatic Cancer Developed by College of Pharmacy Researchers

Heralds a new strategy for fighting cancer: Drugs that target two genes at a time

September 12, 2018
·
3 min read
Business

Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer

Crescendo Biologics Ltd today announces that Pavel Pisa, MD, PhD, has been appointed as Chief Medical Officer of the Company with immediate effect.

September 12, 2018
·
3 min read
Business

Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery

Partnership combines Intellegens’ proprietary AI technology withOptibrium’s expertise in predictive modelling and compound design

September 12, 2018
·
3 min read
Medigene AG: Medigene participates at further conferences in September 2018

Medigene AG today announced its participation at the following upcoming investor and scientific conferences:

September 12, 2018
·
1 min read
Business

Oncolytics Biotech® Collaborates with SOLTI to Conduct a Window of Opportunity Study in Breast Cancer with Pelareorep

Oncolytics Biotech® Inc. today announced a clinical collaboration with SOLTI, an academic research group dedicated to clinical and translational research in breast cancer.

September 12, 2018
·
7 min read
Biopharma Company Arecor raises £6m for revolutionary diabetes treatments

Arecor has raised £6 million from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes.

September 12, 2018
·
8 min read
Business

Oncolytics Biotech® Announces a Master Clinical Supply Agreement of an Anti-PD-L1 Checkpoint Inhibitor for use in the Company’s Clinical Program

Oncolytics Biotech® Inc. today announced that it has entered into a Master Clinical Supply Agreement (Agreement) with F. Hoffmann-La Roche Ltd (Roche) to supply atezolizumab (Tecentriq®) for use in the company’s clinical development program.

September 12, 2018
·
3 min read
Deals

MorphoSys AG to be listed in MDAX

MorphoSys AG announced today that its shares will be included in the MDAX as of September 24, 2018 as announced by Deutsche Börse.

September 12, 2018
·
4 min read
Business

Arix Bioscience plc: Changes announced to executive team to accelerate growth and strategy

Changes announced to executive team to accelerate growth and strategy

September 12, 2018
·
3 min read
Business

Merck & IRBM announce pioneering collaboration to advance peptide therapeutics

IRBM signs collaboration agreement with Merck & Co., Inc, Kenilworth, NJ, USA to advance peptide therapeutics

September 12, 2018
·
2 min read